We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+12.78%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$506M
AUM Growth
-$51.4M
Cap. Flow
-$43.2M
Cap. Flow %
-8.54%
Top 10 Hldgs %
27.96%
Holding
739
New
70
Increased
160
Reduced
252
Closed
106

Top Sells

Rank Stock Value
1
THD icon
iShares MSCI Thailand ETF
THD
+$7.93M
2
ECH icon
iShares MSCI Chile ETF
ECH
+$6.49M
3
BA icon
Boeing
BA
+$6.44M
4
LIN icon
Linde
LIN
+$6.16M
5
CC icon
Chemours
CC
+$4.87M

Sector Composition

Rank Sector Weight
1 Materials 9.77%
2 Energy 7.83%
3 Technology 7.77%
4 Financials 7.67%
5 Consumer Discretionary 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LLY icon
276
Eli Lilly
LLY
$1.07T
$119K 0.02%
918
-8,717
-90% -$1.06M
BMA icon
277
Banco Macro
BMA
$5.78B
$119K 0.02%
2,601
-525
-17% -$27K
XLF icon
278
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
$118K 0.02%
4,604
CRM icon
279
Salesforce
CRM
$141B
$116K 0.02%
+734
New +$114K
IMMU
280
DELISTED
Immunomedics Inc
IMMU
$115K 0.02%
5,999
+3,753
+167% +$60.5K
TXN icon
281
Texas Instruments
TXN
$254B
$112K 0.02%
1,060
+4
+0.4% +$414
RCI icon
282
Rogers Communications
RCI
$17.7B
$111K 0.02%
+2,070
New +$112K
AGN
283
DELISTED
Allergan plc
AGN
$111K 0.02%
761
-1,552
-67% -$225K
BUD icon
284
PUT
AB InBev
BUD
$155B
$111K 0.02%
618
+420
+212% +$32.3K
RARE icon
285
Ultragenyx Pharmaceutical
RARE
$2.65B
$111K 0.02%
1,601
+783
+96% +$44.7K
IYR icon
286
iShares US Real Estate ETF
IYR
$4.74B
$108K 0.02%
1,240
-860
-41% -$71.1K
WM icon
287
Waste Management
WM
$96B
$108K 0.02%
1,035
-10,853
-91% -$1.06M
XEL icon
288
Xcel Energy
XEL
$51B
$106K 0.02%
1,883
-238
-11% -$12.7K
RGLD icon
289
Royal Gold
RGLD
$17.1B
$104K 0.02%
1,146
-409
-26% -$35.7K
RACE icon
290
PUT
Ferrari
RACE
$66.2B
$103K 0.02%
795
+505
+174% +$61.8K
TCBI icon
291
Texas Capital Bancshares
TCBI
$4.32B
$101K 0.02%
1,857
-413
-18% -$23.9K
PCG icon
292
PG&E
PCG
$47.6B
$99.2K 0.02%
5,574
-98
-2% -$1.58K
NOK icon
293
Nokia
NOK
$50.6B
$98.6K 0.02%
17,246
+5,288
+44% +$32.4K
HLT icon
294
Hilton Worldwide
HLT
$74.4B
$95.5K 0.02%
1,149
+173
+18% +$13.5K
TMO icon
295
Thermo Fisher Scientific
TMO
$210B
$94.9K 0.02%
347
+173
+99% +$43.1K
GS icon
296
Goldman Sachs
GS
$313B
$94.8K 0.02%
494
-554
-53% -$107K
NCLH icon
297
Norwegian Cruise Line
NCLH
$9.17B
$94.7K 0.02%
1,724
+504
+41% +$26K
ISRG icon
298
Intuitive Surgical
ISRG
$127B
$93.5K 0.02%
492
+249
+102% +$44.3K
LULU icon
299
lululemon athletica
LULU
$13.2B
$93K 0.02%
568
+241
+74% +$35.2K
TFX icon
300
Teleflex
TFX
$5.93B
$93K 0.02%
308
+151
+96% +$42.1K

Similar funds

Exane Derivatives's Q1 2019 Portfolio in Review

As of Q1 2019, Exane Derivatives held 739 positions worth $506M, down 9.2% from $557M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Exane Derivatives withdrew a net $43.2M in Q1 2019, closing 106 positions and reducing 252 holdings. Its most notable exit was Boeing, an estimated $6.44M position sold in full.

By sector, the portfolio is most concentrated in Materials at 9.8% of assets, down from 11% a quarter earlier, followed by Energy and Technology.

Against the trend, Exane Derivatives opened a new position in UBS Group worth $11.2M.

  • Exane Derivatives's largest Q1 2019 buy was UBS Group: 919,334 shares worth $11.2M.
  • Exane Derivatives added most to iShares MSCI Philippines ETF in Q1 2019, an estimated $9.69M increase.
  • Exane Derivatives's biggest Q1 2019 reduction was iShares MSCI Thailand ETF, cutting an estimated $7.93M.
  • Exane Derivatives fully exited Boeing in Q1 2019, selling an estimated $6.44M.
  • Exane Derivatives's ten largest holdings make up 28% of its $506M portfolio in Q1 2019.
  • Exane Derivatives opened 70 new positions and closed 106 in Q1 2019.
  • Exane Derivatives's portfolio value fell 9.2% quarter-over-quarter to $506M.

Based on Exane Derivatives's 13F filing for Q1 2019, filed 24 Apr 2019.